Merck & Co. Files Q1 2025 10-Q
Ticker: MRK · Form: 10-Q · Filed: May 2, 2025 · CIK: 310158
Sentiment: neutral
Topics: 10-Q, quarterly-report, financials
TL;DR
Merck's Q1 2025 10-Q is in: check financials for latest performance.
AI Summary
Merck & Co., Inc. filed its 10-Q for the period ending March 31, 2025. The filing details the company's financial performance and position. Key financial data points such as revenue, net income, and cash flows for the quarter are presented, along with balance sheet information as of March 31, 2025.
Why It Matters
This filing provides investors with the latest financial results and operational updates for Merck & Co., Inc., crucial for assessing the company's performance and future prospects.
Risk Assessment
Risk Level: low — This is a routine quarterly filing providing standard financial information.
Key Players & Entities
- Merck & Co., Inc. (company) — Filer of the 10-Q
- 20250331 (date) — End of the reporting period
- 20250502 (date) — Filing date
- 0000310158 (company) — Central Index Key for Merck & Co., Inc.
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is the quarter ended March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 2, 2025.
What is Merck & Co., Inc.'s Central Index Key (CIK)?
Merck & Co., Inc.'s Central Index Key is 0000310158.
What is Merck & Co., Inc.'s fiscal year end?
Merck & Co., Inc.'s fiscal year ends on December 31.
What is the primary business of Merck & Co., Inc. according to the SIC code?
According to the Standard Industrial Classification (SIC) code, Merck & Co., Inc. is in the 'Pharmaceutical Preparations' industry.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 2, 2025 regarding Merck & Co., Inc. (MRK).